"Drug Sales in the Global Anti-Obesity Market Approached $2bn in 2008 & Will be Increase in Next Years," Says Visiongain Report

Anti-Obesity Treatments Report - Analysis & Forecasts 2009-2024. Obesity has been described as a 'public health time-bomb'. In 2005, the World Health Organization estimated that approximately 400 million individuals are obese. Prevalence of obesity is rising worryingly in many countries, despite campaigns emphasising the link between being overweight and contracting diabetes. - May 30, 2009

"The World Health Organization Estimates the Number of Diabetics to Exceed 350bn by 2030," Announced by Visiongain Report

World Diabetes Market Analysis, 2009-2023. The diabetes treatment market worldwide was worth over $25 billion, and had double-digit growth from the year before.This report also covers the new GLP-1 analogues – such as Byetta and liraglutide - as well as potentially revolutionary insulin delivery technologies. - May 30, 2009

"The Worldwide UAV Market Will Expand Significantly Next Decade," Announced by Brand New Visiongain Defence Report

The Unmanned Aerial Vehicles (UAV) Market 2009-2019. Visiongain market study reviews leading UAV programmes and products, with the prospects and outlook for providers of UAV systems and technologies. - May 28, 2009

"Rx-to-OTC Switching and the Continuing Importance of Emerging Pharma Markets Will Drive OTC Sales Growth from 2009 Onwards," Announced Visiongain Brand New Report

OTC pharma is influenced by changes in consumer spending - but significant commercial opportunities for OTC switching will drive market expansion worldwide – Visiongain new report explains. - May 24, 2009

"IP Multimedia Subsystem (IMS) is an Open and Standardised Architecture for Mobile and Fixed services.", Says Visiongain Brand New Telecoms Report

This updated version of the IMS 2009 report provides a critical insight into the different aspects of IMS strategy adopted by various operators across the globe. The report also seeks to dispel the hype and confusion surrounding IMS. We aim to describe the technology itself, its readiness for deployment and its compatibility with existing infrastructure. - May 22, 2009

"Mobile Social Networking and User Generated Content Revenue Will Grow to Around $60 Billion in 2012," Says Visiongain Telecoms Report

Mobile Social Networking and User Generated Content Market Insight 2009-2014. Mobile operators wish to recreate this success, but there are key challenges to be faced in transferring such popular applications from fixed-line to mobile. - May 22, 2009

"Mobile Money Also Enables Financial Services & Money Transfers - Often Initiated by Urban & International Immigrants - to Reach Poor People in Rural Areas." Visiongain.

Mobile Money Transfer Report 2009: Profiting from cross-border remittance and global banking. The huge potential for mobile money transfer can be seen from the sheer volume of cross-border remittances typically sent through existing channels such as banks and money transfer agencies. - May 22, 2009

"The Ability to Carry Out Email Whilst on the Move Thus Has Huge Potential and Will be Attractive to a Huge Pool of clientele", Says Visiongain Telecoms Report

Mobile Email 2009: Challenging Blackberry and succeeding in the consumer market. Every day 210 million emails are sent over fixed line internet, with sending and receiving emails being the most popular activity carried out on the internet followed by search. - May 22, 2009

Apple Has Witnessed the iPhone Becoming a Cultural Near Phenomenon, & Maintain a Balance, Its AppStore & iTunes Offering on the Device, Announced Visiongain Report

Apple's iPhone & Mobile Report 2009: Competing successfully with Devices, Content & Services from Apple. Apple's process of growth and product leadership has taken place in a relatively short time frame, but this report will show how rivals can compete given the current composition of the mobile value chain, with pressure on margins intensifying. - May 22, 2009

Monoclonal Antibodies in Cancer Therapy – Significant Commercial Opportunities with Developing Technologies and Innovative Products - Visiongain New Report Explains

Monoclonal Antibodies in Cancer Therapy 2009-2024. Monoclonal antibody-based therapies for cancer are a thriving part of the biotechnology sector, as their new market report explains. The oncology market continues to expand worldwide, with high demand for more-efficacious and better-tolerated cancer therapies. - May 20, 2009

Parkinson's Disease: Market Analysis and Forecasts, 2008-2012, 2017 & 2022

Visiongain is proud to announce the release of the brand new report "Parkinson's Diseases Market Analysis." In 2006, the global sales of PD therapeutics were $3.1bn up by 11% from $2.5bn in 2005. - May 15, 2009

‘AdMob Overall Winner at the MAMAs Awards’, Says Visiongain

The MAMAs conference and awards dinner was a resounding success at the prestigious Charing Cross hotel with AdMob taking home the overall winner trophy. - May 15, 2009

Press Releases 151 - 162 of 162